North America Epilepsy Devices Market Forecast 2022-2030
Description
North America Epilepsy Devices Market Forecast 2022-2030
KEY FINDINGS
The North America epilepsy devices market is predicted to increase with an 8.01% CAGR by the end of the forecast period, 2022-2030. The key players in the region are spending extensively on the research and development of new products, getting new product approvals, and innovating technologies, driving the market growth.
MARKET INSIGHTS
The North America epilepsy devices market growth assessment includes the evaluation of the United States and Canada. According to the Canadian Epilepsy Alliance, there are around 260,000 epileptics in Canada. 78,000 of them, or 30%, have drug-resistant epilepsy. Canada’s healthcare system is funded by public and private sectors, primarily private insurance and out-of-pocket expenses. Spending on public health care in Canada has increased and is anticipated to support market expansion. The population of Canada has increased, and decision-makers in the health system must consider the effects of this growth on the prospective demand for healthcare services in the future.
The greatest demographic segment in recent Canadian history is reaching 65. The consensus is that an aging population would result in higher demands for medical services and a faster pace of increase in health spending. Hospitals in Canada now have more installed and operational computed tomography (CT) and magnetic resonance imaging (MRI) machines. The capacity of medical imaging technologies to identify more anomalies has expanded hospital services.
COMPETITIVE INSIGHTS
Leading companies operating in the market include Cadwell Industries Inc, Empatica Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
KEY FINDINGS
The North America epilepsy devices market is predicted to increase with an 8.01% CAGR by the end of the forecast period, 2022-2030. The key players in the region are spending extensively on the research and development of new products, getting new product approvals, and innovating technologies, driving the market growth.
MARKET INSIGHTS
The North America epilepsy devices market growth assessment includes the evaluation of the United States and Canada. According to the Canadian Epilepsy Alliance, there are around 260,000 epileptics in Canada. 78,000 of them, or 30%, have drug-resistant epilepsy. Canada’s healthcare system is funded by public and private sectors, primarily private insurance and out-of-pocket expenses. Spending on public health care in Canada has increased and is anticipated to support market expansion. The population of Canada has increased, and decision-makers in the health system must consider the effects of this growth on the prospective demand for healthcare services in the future.
The greatest demographic segment in recent Canadian history is reaching 65. The consensus is that an aging population would result in higher demands for medical services and a faster pace of increase in health spending. Hospitals in Canada now have more installed and operational computed tomography (CT) and magnetic resonance imaging (MRI) machines. The capacity of medical imaging technologies to identify more anomalies has expanded hospital services.
COMPETITIVE INSIGHTS
Leading companies operating in the market include Cadwell Industries Inc, Empatica Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
152 Pages
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Soaring Occurrences Of Epilepsy North Americaly
- 3.1.2. Onset Of Epilepsy In Elderly People
- 3.1.3. Mitigation Of Epilepsy Using Early Diagnosis
- 3.1.4. Surge In Post-traumatic Epilepsy With Rising Brain Injury Cases
- 3.2. Key Restraints
- 3.2.1. Misperceptions And Misinformation About Epilepsy
- 3.2.2. Shortage Of Neurology Specialists In The Healthcare System
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Epilepsy Devices Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Comfort & Usability
- 4.7.2. Product Features
- 4.7.3. Confidentiality
- 4.8. Regulatory Framework
- 5. Market By Product Type
- 5.1. Conventional Devices
- 5.2. Wearable Devices
- 5.2.1. Watches
- 5.2.2. Bracelets
- 5.2.3. Camera Devices
- 5.2.4. Mattress Devices
- 5.2.5. Anti-suffocation Pillows
- 5.2.6. Other Wearable Devices
- 5.3. Implantable Devices
- 6. Market By Technology
- 6.1. Vagus Nerve Stimulation
- 6.2. Deep Brain Stimulation
- 6.2.1. Movement Disorders
- 6.2.2. Epilepsy
- 6.3. Accelerometry
- 6.4. Responsive Neurostimulation
- 7. Market By Detection & Prediction Devices Type
- 7.1. Electroencephalogram
- 7.2. Intracranial Eeg
- 7.3. Surface Electromyography
- 7.4. Electrocardiography
- 7.5. Video Detection Systems
- 7.6. Electrodermal Activity
- 7.7. Implanted Advisory Systems
- 7.8. Other Detection & Prediction Device Types
- 8. Market By End-user
- 8.1. Hospitals & Clinics
- 8.2. Neurology Centers
- 8.3. Home Care Settings
- 8.4. Other End-users
- 9. Geographical Analysis
- 9.1. North America
- 9.1.1. Market Size & Estimates
- 9.1.2. Key Growth Enablers
- 9.1.3. Key Challenges
- 9.1.4. Key Players
- 9.1.5. Country Analysis
- 9.1.5.1. United States
- 9.1.5.2. Canada
- 10. Competitive Landscape
- 10.1. Key Strategic Developments
- 10.1.1. Acquisitions
- 10.1.2. Product Launches & Developments
- 10.1.3. Partnerships
- 10.2. Company Profiles
- 10.2.1. Boston Scientific Corporation
- 10.2.2. Cadwell Industries Inc
- 10.2.3. Compumedics Limited
- 10.2.4. Drägerwerk Ag & Co Kgaa
- 10.2.5. Empatica Inc
- 10.2.6. Koninklijke Philips Nv
- 10.2.7. Livanova Plc
- 10.2.8. Medtronic Plc
- 10.2.9. Natus Medical Incorporated
- 10.2.10. Neuropace Inc
- 10.2.11. Neurosoft
- 10.2.12. Nihon Kohden Corporation
- 10.2.13. Shenzhen Mindray Bio-medical Electronics Co Ltd
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
